According to MD Magazine online, research presented at the American College of Rheumatology 2015 meeting suggests that using a combination of two of the three existing tools designed to assess the quality of life (QOL) in psoriatic arthritis (PsA) patients will provide more accurate analysis than using only one. The tools examined in the study, include Psoriatic Arthritis Quality of Life (PsAQol), the Ankylosing Spondylitis Quality of Life (ASQoL), and the Dermatology Life Quality Index (DLQI).
According to researchers, each tool has its benefits and disadvantages in assessing QOL for those with PsA. “The data suggest that PsAQoL does not cover the full spectrum of health-related quality of life in psoriasis,” the study authors concluded. “Conversely, DLQI does not cover the full spectrum of health-related quality of life of articular disease in psoriatic arthritis. PsAQoL, (or ASQoL) and DLQI complement each other in capturing both joint and skin aspects of health-related quality of life.”
Findings suggest that utilizing a combination of the tools help better cover the full spectrum of QOL in PsA.